For those of you who would like to take advantage of our Luck O' the Irish SALE but prefer not to make payments online, you are welcome to send us a check or money order in the amount of $114.12 for a 3-year AD-FREE Premium Service Bundle or $190.20 for a 5-year Bundle. Make checks or money orders payable in US funds to "Investor Village" and send to: Investor Village, P.O. Box 2958, Marrero, LA 70073.
As many of you know, we operate on the honor system around here. So, in closing out our Luck O' the Irish SALE, we wanted to advise those of you who plan to pay by check or money order that you can send a PM to Admin informing us of your intention. We will then upgrade your account for 7 days, allowing you to enjoy our ad-free premium service now and giving you a reasonable amount of time to get your payment in.
The following message was updated on 1/11/2017 3:52:03 PM.
re: apart from the potential CAR-T applications, SGMO's programs should be confined primarily to autologous HSCs (e.g., the BCL11a enhancer program) so #1 about improved conditioning regimens to "make room" for gene edited HSCs is worth reading
I've posted previously about reviews that summarize "state of the art" approaches to hematopoietic stem cell (HSC) gene editing mentioning that less toxic conditioning regimens are desirable and emerging.
Note the statement in #1, that for Bluebird's trials "their main toxicities, so far have been due to conditioning regimens", so obviously any process of depleting existing HSCs w/ less toxicity will be welcome, & should be helpful to incorporate into SGMO's HSC-related gene editing trials, if possible.
As you'll recall, these condition regimens are designed to deplete existing HSCs in bone marrow to "make room" for the engraftment of newly transplanted gene edited, HSCs.